Obesity and type 2 diabetes: which patients are at risk? von Garber, A. J.

Volltext

Will the next generation of basal insulins offer clinical advantages? von Garber, A. J.

Volltext

Methods to enhance delivery of prandial insulin and basal-prandial insulin von Garber, A. J.

Volltext

Treat-to-target trials: uses, interpretation and review of concepts von Garber, A. J.

Volltext

Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study) von Garber, A. J., Wahlen, J., Wahl, T., Bressler, P., Braceras, R., Allen, E., Jain, R.

Volltext

Effect of insulin degludec versus sitagliptin in patients with type 2 diabetes uncontrolled on oral antidiabetic agents von Philis-Tsimikas, A., Del Prato, S., Satman, I., Bhargava, A., Dharmalingam, M., Skjøth, T. V., Rasmussen, S., Garber, A. J.

Volltext

Efficacy of Metformin in Type II Diabetes: Results of a Double-Blind, Placebo-controlled, Dose-Response Trial von Garber, Alan J., Duncan, Theodore G., Goodman, Anita M., Mills, Donna J., Rohlf, Jane L.

Volltext

Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a... von Jendle, J, Nauck, M.A, Matthews, D.R, Frid, A, Hermansen, K, Düring, M, Zdravkovic, M, Strauss, B.J, Garber, A.J

Volltext

Vildagliptin in combination with pioglitazone improves glycaemic control in patients with type 2 diabetes failing thiazolidinedione monotherapy: a randomized, placebo-controlled st... von Garber, A. J., Schweizer, A., Baron, M. A., Rochotte, E., Dejager, S.

Volltext

Liraglutide in oral antidiabetic drug combination therapy von Garber, A. J.

Volltext

Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea von Garber, A.J, Foley, J.E, Banerji, M.A, Ebeling, P, Gudbjörnsdottir, S, Camisasca, R.-P, Couturier, A, Baron, M.A

Volltext

What is the best approach to glycaemic control in patients with type 2 diabetes? von Garber, A. J.

Volltext

Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes von Garber, A. J., Larsen, J., Schneider, S. H., Piper, B. A., Henry, D.

Volltext

Non-glycaemic effects mediated via GLP-1 receptor agonists and the potential for exploiting these for therapeutic benefit: focus on liraglutide von Vilsbøll, T., Garber, A. J.

Volltext

Current challenges in type 2 diabetes von Garber, A. J.

Volltext

Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus i... von Hollander, P., King, A. B., Del Prato, S., Sreenan, S., Balci, M. K., Muñoz-Torres, M., Rosenstock, J., Hansen, C. T., Niemeyer, M., Garber, A. J.

Volltext

Insulin intensification strategies in type 2 diabetes: when one injection is no longer sufficient von Garber, A.J

Volltext

importance of titrating starting insulin regimens in patients with type 2 diabetes von Garber, A.J

Volltext

Restaging insulin therapy for patients with type 2 diabetes von Garber, A.J

Volltext

importance of early insulin secretion and its impact on glycaemic regulation von Garber, A.J

Volltext